These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26122791)

  • 1. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine.
    Stahl SM
    CNS Spectr; 2015 Oct; 20(5):455-9. PubMed ID: 26122791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors).
    Stahl SM
    CNS Spectr; 2015 Apr; 20(2):93-7. PubMed ID: 25831967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions at serotonin receptors may enhance downstream release of four pro-cognitive neurotransmitters.
    Stahl SM
    CNS Spectr; 2015 Dec; 20(6):515-9. PubMed ID: 26062986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
    Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
    J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.
    Bétry C; Pehrson AL; Etiévant A; Ebert B; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):1115-27. PubMed ID: 23089374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): modifying serotonin's downstream effects on glutamate and GABA (gamma amino butyric acid) release.
    Stahl SM
    CNS Spectr; 2015 Aug; 20(4):331-6. PubMed ID: 26062900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
    Riga MS; Sánchez C; Celada P; Artigas F
    Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional distribution of serotonergic receptors: a systems neuroscience perspective on the downstream effects of the multimodal-acting antidepressant vortioxetine on excitatory and inhibitory neurotransmission.
    Pehrson AL; Jeyarajah T; Sanchez C
    CNS Spectr; 2016 Apr; 21(2):162-83. PubMed ID: 26250622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory.
    Bétry C; Etiévant A; Pehrson A; Sánchez C; Haddjeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():38-46. PubMed ID: 25524057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT
    Dale E; Grunnet M; Pehrson AL; Frederiksen K; Larsen PH; Nielsen J; Stensbøl TB; Ebert B; Yin H; Lu D; Liu H; Jensen TN; Yang CR; Sanchez C
    Brain Res; 2018 Jun; 1689():1-11. PubMed ID: 29274875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo electrophysiological study of the targeting of 5-HT
    Schweimer JV; Brouard JT; Li Y; Sánchez C; Sharp T
    Eur J Neurosci; 2022 Mar; 55(6):1409-1423. PubMed ID: 35146812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
    Nackenoff AG; Simmler LD; Baganz NL; Pehrson AL; Sánchez C; Blakely RD
    ACS Chem Neurosci; 2017 May; 8(5):1092-1100. PubMed ID: 28272863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the multimodal antidepressant drug vortioxetine to the human serotonin transporter.
    Andersen J; Ladefoged LK; Wang D; Kristensen TN; Bang-Andersen B; Kristensen AS; Schiøtt B; Strømgaard K
    ACS Chem Neurosci; 2015 Nov; 6(11):1892-900. PubMed ID: 26389667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats.
    Mørk A; Montezinho LP; Miller S; Trippodi-Murphy C; Plath N; Li Y; Gulinello M; Sanchez C
    Pharmacol Biochem Behav; 2013 Apr; 105():41-50. PubMed ID: 23380522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.
    Sanchez C; Asin KE; Artigas F
    Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice.
    Guilloux JP; Mendez-David I; Pehrson A; Guiard BP; Repérant C; Orvoën S; Gardier AM; Hen R; Ebert B; Miller S; Sanchez C; David DJ
    Neuropharmacology; 2013 Oct; 73():147-59. PubMed ID: 23721744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5HT3 receptors: Target for new antidepressant drugs.
    Gupta D; Prabhakar V; Radhakrishnan M
    Neurosci Biobehav Rev; 2016 May; 64():311-25. PubMed ID: 26976353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of vortioxetine.
    Schatzberg AF; Blier P; Culpepper L; Jain R; Papakostas GI; Thase ME
    J Clin Psychiatry; 2014 Dec; 75(12):1411-8. PubMed ID: 25551236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.
    du Jardin KG; Jensen JB; Sanchez C; Pehrson AL
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of vortioxetine and duloxetine on resting-state functional connectivity in the awake rat.
    Pérez PD; Ma Z; Hamilton C; Sánchez C; Mørk A; Pehrson AL; Bundgaard C; Zhang N
    Neuropharmacology; 2018 Jan; 128():379-387. PubMed ID: 29104073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.